ECHO THERAPEUTICS Debt Non Current Trend from 2010 to 2022

ECTE -  USA Stock  

USD 0.0002  0.00  0.00%

ECHO THERAPEUTICS Debt Non Current is increasing over the years with slightly volatile fluctuation. Ongoing Debt Non Current is projected to grow to about 151.6 K this year. During the period from 2010 to 2022 ECHO THERAPEUTICS Debt Non Current anual values regression line had geometric mean of 76,565 and significance of  0.005965. ECHO THERAPEUTICS Interest Expense is projected to decrease significantly based on the last few years of reporting. The past year's Interest Expense was at 17,644.45. The current year Preferred Dividends Income Statement Impact is expected to grow to about 323.3 K, whereas Earning Before Interest and Taxes EBIT is forecasted to decline to (21.5 M).

ECHO THERAPEUTICS Historical Trends 

 
Refresh
Check ECHO THERAPEUTICS financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ECHO THERAPEUTICS main balance sheet or income statement drivers, such as Gross Profit of 52.9 K, Interest Expense of 18.1 K or Operating Expenses of 18.2 M, as well as many exotic indicators such as Asset Turnover of 0.0028, Current Ratio of 0.0859 or Gross Margin of 0.89. ECHO THERAPEUTICS financial statements analysis is a perfect complement when working with ECHO THERAPEUTICS Valuation or Volatility modules. It can also supplement various ECHO THERAPEUTICS Technical models. Continue to Investing Opportunities.

ECHO THERAPEUTICS Quarterly Debt Non Current

0.0Share

ECHO THERAPEUTICS Debt Non Current Breakdown

Showing smoothed Debt Non Current of ECHO THERAPEUTICS INC with missing and latest data points interpolated. The non-current portion of Total Debt reported if the company operates a classified balance sheet that segments current and non-current liabilities.ECHO THERAPEUTICS's Debt Non Current historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ECHO THERAPEUTICS's overall financial position and show how it may be relating to other accounts over time.
Debt Non Current10 Years Trend
Increasing
Slightly volatile
 Debt Non Current 
Share
      Timeline 

ECHO THERAPEUTICS Debt Non Current Regression Statistics

Arithmetic Mean 107,843
Geometric Mean 76,565
Coefficient Of Variation 43.15
Mean Deviation 31,634
Median 122,195
Standard Deviation 46,530
Range 147,730
R-Value 0.72
R-Squared 0.51
Significance 0.005965
Slope 8,549

ECHO THERAPEUTICS Debt Non Current History

2010  6,176 
2011  3,888 
2012122.2 K
2021140.5 K
2022151.6 K

About ECHO THERAPEUTICS Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include ECHO THERAPEUTICS income statement, its balance sheet, and the statement of cash flows. ECHO THERAPEUTICS investors use historical funamental indicators, such as ECHO THERAPEUTICS's Debt Non Current, to determine how well the company is positioned to perform in the future. Although ECHO THERAPEUTICS investors may use each financial statement separately, they are all related. The changes in ECHO THERAPEUTICS's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on ECHO THERAPEUTICS's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on ECHO THERAPEUTICS Financial Statements. Understanding these patterns can help to make the right decision on long term investment in ECHO THERAPEUTICS. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Debt Non Current140.5 K151.6 K
Echo Therapeutics, Inc. engages in the development of transdermal skin permeation and diagnostic medical devices for wearable-health consumer and diabetes outpatient markets. The company was founded in 1989 and is headquartered in Iselin, New Jersey. Echo Therapeutics operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 19 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in ECHO THERAPEUTICS without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Efficient Frontier Now

   

Efficient Frontier

Plot and analyze your portfolio and positions against risk-return landscape of the market.
All  Next Launch Module

Pair Trading with ECHO THERAPEUTICS

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ECHO THERAPEUTICS position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ECHO THERAPEUTICS will appreciate offsetting losses from the drop in the long position's value.

ECHO THERAPEUTICS Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for ECHO THERAPEUTICS and Bio-Rad Laboratories. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Continue to Investing Opportunities. Note that the ECHO THERAPEUTICS INC information on this page should be used as a complementary analysis to other ECHO THERAPEUTICS's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Tools for ECHO THERAPEUTICS Stock

When running ECHO THERAPEUTICS INC price analysis, check to measure ECHO THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ECHO THERAPEUTICS is operating at the current time. Most of ECHO THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of ECHO THERAPEUTICS's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move ECHO THERAPEUTICS's price. Additionally, you may evaluate how the addition of ECHO THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go